Therapeutic Response to Secukinumab in a 36-Year-Old Woman with Hidradenitis Suppurativa

Figure 1

Clinical parameters during treatment of HS with secukinumab. HSS: Hidradenitis Suppurativa Score; DLQI: Dermatology Life Quality Index; VAS: visual analogue scale; IHS4: International Hidradenitis Suppurativa Severity Score System.